SEVERAL PATIENTS WHO HAVE OVERCOME CORONAVIRUS DISEASE (COVID-19) HAVE BEEN LEFT WITH CARDIOVASCULAR AND PULMONARY SEQUELAE AND MOST MEDICAL CENTERS LACK A REMOTE MONITORING SYSTEM FOR EACH PATIENT THAT NOTIFIES THEM OF ANY COMPLICATIONS DURING REHABILITATION. THE OBJECTIVE OF THIS RESEARCH WAS TO IMPLEMENT A WEARABLE THAT MONITORS THE PATIENT’S HEALTH AND ALERTS IN CASE OF DETECTING ANY ANOMALY. FOR THIS REASON, A WEARABLE WAS DEVELOPED THAT DISPLAYS THE PATIENT’S HEART RATE, OXYGEN SATURATION (SPO2) LEVEL AND BODY TEMPERATURE ON THE LIGHT EMITTING DIODE (LCD) AND THE APPLICATION MOBILE, SENDING AN ALERT AND GEOLOCATION MESSAGE IF ANOMALIES ARE DETECTED IN VITAL SIGNS. THE STANDARD DEVIATION OF HEART RATE, TEMPERATURE AND SPO2 WAS OBTAINED, WHICH WAS 1.4930, 0.1558, AND 0.4364 IN THE REST STAGE, RESPECTIVELY, AND 6.3442, 0.2365, AND 0.9186 IN THE PHYSICAL ACTIVITY STAGE RESPECTIVELY...

ALZHEIMER’S IS A PROGRESSIVE DISEASE THAT AFFECTS MEMORY, CAUSING DISORIENTATION IN THE PATIENT, WHICH CAUSES THEM TO LOSE THEMSELVES, GENERATING ANGUISH IN FAMILIES WHO HAVE TO RESORT TO EXPENSIVE SEARCHES. THE OBJECTIVE OF THIS RESEARCH WAS TO IMPLEMENT A DEVICE THAT CAN REMOTELY PROVIDE THE LOCATION OF THE ALZHEIMER’S PATIENT OVER A LONG PERIOD TO RELATIVES FOR GREATER SECURITY. FOR THIS, IN THIS RESEARCH, A MOBILE APPLICATION WAS DEVELOPED THAT RECEIVES INFORMATION FROM A WEARABLE THAT APPLIES THE INTERNET OF THINGS USING LONG-RANGE WIDE AREA TECHNOLOGY TO SHOW THE PATIENT’S REAL-TIME LOCATION AND USES PIEZOELECTRICS FOR GREATER BATTERY AUTONOMY. THE REAL-TIME LOCATION OF THE PERSON AND THE RADIUS OF THE SAFE ZONE IN THE APPLICATION WERE OBTAINED AS RESULTS, THE RECEIVED SIGNAL STRENGTH INDICATOR VALUE WHERE THE SIGNAL WAS EXCELLENT OR GOOD HAD A VALUE OF -30 TO -89 DB BETWEEN ...